PM

Pruthviraj Mahadev Wandre

Active Director Director DIN 11809303
DIN 11809303 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pruthviraj Mahadev Wandre

Pruthviraj Mahadev Wandre is a Director at Mahapruthvi Pharma Private Limited (since 2026).

DIN 11809303
Primary Designation Director
First Appointment 07 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mahapruthvi Pharma Private Limited U21002PN2026PTC257427
Director07 Jul 20262026Active

Board colleagues of Pruthviraj Mahadev Wandre

NameDINCompanyDesignation
Amey Mahadev Wandre11809304Mahapruthvi Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mahapruthvi Pharma Private Limited
Premium access

Shareholding and investment profile for Pruthviraj Mahadev Wandre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pruthviraj Mahadev Wandre

Pruthviraj Mahadev Wandre currently holds 1 directorship: Mahapruthvi Pharma Private Limited (Director, since 07 Jul 2026).

Pruthviraj Mahadev Wandre was first appointed on 07 Jul 2026 as Director at Mahapruthvi Pharma Private Limited.

The current boards of Pruthviraj Mahadev Wandre's companies include Amey Mahadev Wandre (Mahapruthvi Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available